QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
NASDAQ:OGI

Organigram - OGI Stock Forecast, Price & News

$0.89
-0.03 (-3.26%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.88
$0.93
50-Day Range
$0.70
$1.19
52-Week Range
$0.70
$1.87
Volume
1.19 million shs
Average Volume
1.38 million shs
Market Capitalization
$279.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.67

Organigram MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
87.3% Upside
$1.67 Price Target
Short Interest
Healthy
1.97% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.51mentions of Organigram in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.05) to ($0.03) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Medical Sector

478th out of 1,049 stocks

Pharmaceutical Preparations Industry

233rd out of 514 stocks


OGI stock logo

About Organigram (NASDAQ:OGI) Stock

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was incorporated in 2010 and is headquartered in Toronto, Canada.

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter.

OGI Stock News Headlines

MarketBeat: Week in Review 11/28 – 12/02 (OGI)
Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this week
OGI.TO - | Stock Price & Latest News | Reuters
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
Organigram Provides NASDAQ Listing Update
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Stocks in play: Organigram Holdings Inc.
Organigram Holdings Inc. Common Shares (OGI)
See More Headlines
Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter.

OGI Company Calendar

Last Earnings
11/28/2022
Today
1/30/2023
Next Earnings (Estimated)
4/11/2023
Fiscal Year End
8/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OGI
Fax
N/A
Employees
841
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$1.67
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+87.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-11,230,000.00
Pretax Margin
-5.41%

Debt

Sales & Book Value

Annual Sales
$111.27 million
Book Value
$1.27 per share

Miscellaneous

Free Float
313,575,000
Market Cap
$279.24 million
Optionable
Not Optionable
Beta
0.82

Key Executives

  • Mr. Derrick W. West CPA (Age 56)
    CPA, (CA), Chief Financial Officer
    Comp: $233.17k
  • Ms. Helen Martin (Age 45)
    Chief Legal Officer & Corp. Sec.
    Comp: $218.39k
  • Mr. Gregory Engel (Age 58)
    Special Advisor
    Comp: $436.86k
  • Mr. Timothy Emberg
    Chief Revenue Officer
  • Mr. Paolo De Luca C.A. (Age 50)
    C.F.A, Chief Strategy Officer
    Comp: $230.09k
  • Ms. Beena G. Goldenberg (Age 60)
    CEO & Director
  • Ms. Nathalie Batten
    VP of Operations
  • Mr. Geoff Riggs
    Chief Information Officer
  • Amy Schwalm
    VP of Investor Relations
  • Ms. Megan Amber McCrae
    Sr. VP of Marketing & Communications













OGI Stock - Frequently Asked Questions

Should I buy or sell Organigram stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OGI shares.
View OGI analyst ratings
or view top-rated stocks.

What is Organigram's stock price forecast for 2023?

2 brokers have issued twelve-month target prices for Organigram's stock. Their OGI share price forecasts range from $1.50 to $2.00. On average, they predict the company's stock price to reach $1.67 in the next twelve months. This suggests a possible upside of 81.2% from the stock's current price.
View analysts price targets for OGI
or view top-rated stocks among Wall Street analysts.

How have OGI shares performed in 2023?

Organigram's stock was trading at $0.80 at the start of the year. Since then, OGI shares have increased by 15.0% and is now trading at $0.92.
View the best growth stocks for 2023 here
.

Are investors shorting Organigram?

Organigram saw a drop in short interest in the month of January. As of January 15th, there was short interest totaling 6,170,000 shares, a drop of 17.0% from the December 31st total of 7,430,000 shares. Based on an average daily trading volume, of 1,270,000 shares, the days-to-cover ratio is currently 4.9 days.
View Organigram's Short Interest
.

When is Organigram's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 11th 2023.
View our OGI earnings forecast
.

How were Organigram's earnings last quarter?

Organigram Holdings Inc. (NASDAQ:OGI) posted its quarterly earnings data on Monday, November, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.02). The business earned $34.71 million during the quarter, compared to analysts' expectations of $32.81 million. Organigram had a negative trailing twelve-month return on equity of 6.00% and a negative net margin of 4.97%.

What other stocks do shareholders of Organigram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE).

What is Organigram's stock symbol?

Organigram trades on the NASDAQ under the ticker symbol "OGI."

How do I buy shares of Organigram?

Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Organigram's stock price today?

One share of OGI stock can currently be purchased for approximately $0.92.

How much money does Organigram make?

Organigram (NASDAQ:OGI) has a market capitalization of $288.75 million and generates $111.27 million in revenue each year. The company earns $-11,230,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis.

How many employees does Organigram have?

The company employs 841 workers across the globe.

How can I contact Organigram?

Organigram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for the company is www.organigram.ca. The company can be reached via phone at (844) 644-4726.

This page (NASDAQ:OGI) was last updated on 1/30/2023 by MarketBeat.com Staff